Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer
Crossref DOI link: https://doi.org/10.1186/s13014-016-0758-8
Published Online: 2017-01-13
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Boyer, Matthew J.
Papagikos, Michael A.
Kiteley, Rex
Vujaskovic, Zeljko
Wu, Jackie
Lee, W. Robert